MedTrace Logo

Adaptive Cardiac Resynchronization Therapy Study

NCT00980057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 522

Last updated 2018-10-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate the AdaptivCRT algorithm is at least as good as manual echo based optimization in regard to patient outcomes and cardiac performance

Conditions

Interventions

DEVICE

Adaptive CRT (aCRT)

Adaptive CRT (aCRT) is an algorithm, which provides ambulatory adjustment of pacing configuration (LV-only or BiV) and AV and VV delays based on periodic automatic evaluation of electrical conduction to optimize cardiac function

DEVICE

Echo

Standard BiV pacing with settings optimized using a standardized echocardiographic protocol

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Adaptive CRT Trial Leader · Medtronic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-01
Primary Completion
2011-08-04
Completion
2012-03-08

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Canada
  • Denmark
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Italy
  • Japan
  • Netherlands
  • Norway
  • Russia
  • Saudi Arabia
  • Serbia
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00980057 on ClinicalTrials.gov